Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery.

Agüeros M, Espuelas S, Esparza I, Calleja P, Peñuelas I, Ponchel G, Irache JM.

Expert Opin Drug Deliv. 2011 Jun;8(6):721-34. doi: 10.1517/17425247.2011.572069. Epub 2011 Apr 4. Review.

PMID:
21463219
2.

Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles.

Agüeros M, Zabaleta V, Espuelas S, Campanero MA, Irache JM.

J Control Release. 2010 Jul 1;145(1):2-8. doi: 10.1016/j.jconrel.2010.03.012. Epub 2010 Mar 27.

PMID:
20347897
3.

Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.

Zabaleta V, Ponchel G, Salman H, Agüeros M, Vauthier C, Irache JM.

Eur J Pharm Biopharm. 2012 Aug;81(3):514-23. doi: 10.1016/j.ejpb.2012.04.001. Epub 2012 Apr 10.

PMID:
22516136
4.

Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone.

Calvo J, Lavandera JL, Agüeros M, Irache JM.

Biomed Microdevices. 2011 Dec;13(6):1015-25. doi: 10.1007/s10544-011-9571-1.

PMID:
21773725
5.
6.

Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel.

Agüeros M, Ruiz-Gatón L, Vauthier C, Bouchemal K, Espuelas S, Ponchel G, Irache JM.

Eur J Pharm Sci. 2009 Nov 5;38(4):405-13. doi: 10.1016/j.ejps.2009.09.010. Epub 2009 Sep 16.

PMID:
19765652
7.

Cyclodextrins and carrier systems.

Duchêne D, Wouessidjewe D, Ponchel G.

J Control Release. 1999 Nov 1;62(1-2):263-8.

PMID:
10518659
8.

Molecular buckets: cyclodextrins for oral cancer therapy.

Calleja P, Huarte J, Agüeros M, Ruiz-Gatón L, Espuelas S, Irache JM.

Ther Deliv. 2012 Jan;3(1):43-57. Review.

PMID:
22833932
9.

Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus.

Zhang D, Pan X, Wang S, Zhai Y, Guan J, Fu Q, Hao X, Qi W, Wang Y, Lian H, Liu X, Wang Y, Sun Y, He Z, Sun J.

Mol Pharm. 2015 Jul 6;12(7):2337-51. doi: 10.1021/acs.molpharmaceut.5b00010. Epub 2015 Jun 8.

PMID:
26024817
10.

The use of cyclodextrins nanoparticles for oral delivery.

Kanwar JR, Long BM, Kanwar RK.

Curr Med Chem. 2011;18(14):2079-85. Review.

PMID:
21517768
11.

Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.

Soares AF, Carvalho Rde A, Veiga F.

Nanomedicine (Lond). 2007 Apr;2(2):183-202. Review.

PMID:
17716120
12.

Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles.

Agüeros M, Areses P, Campanero MA, Salman H, Quincoces G, Peñuelas I, Irache JM.

Eur J Pharm Sci. 2009 Jun 28;37(3-4):231-40. doi: 10.1016/j.ejps.2009.02.010. Epub 2009 Feb 28.

PMID:
19491010
13.

Model predicting impact of complexation with cyclodextrins on oral absorption.

Gamsiz ED, Thombre AG, Ahmed I, Carrier RL.

Biotechnol Bioeng. 2013 Sep;110(9):2536-47. doi: 10.1002/bit.24932. Epub 2013 Jul 10.

PMID:
23592239
14.

Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.

Harde H, Das M, Jain S.

Expert Opin Drug Deliv. 2011 Nov;8(11):1407-24. doi: 10.1517/17425247.2011.604311. Epub 2011 Aug 11. Review.

PMID:
21831007
15.

Inorganic matrices: an answer to low drug solubility problem.

Perioli L, Pagano C.

Expert Opin Drug Deliv. 2012 Dec;9(12):1559-72. doi: 10.1517/17425247.2012.733693. Epub 2012 Oct 12. Review.

PMID:
23061519
16.

Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development.

Gamsiz ED, Miller L, Thombre AG, Ahmed I, Carrier RL.

Biotechnol Bioeng. 2010 Feb 1;105(2):409-20. doi: 10.1002/bit.22523.

PMID:
19725042
17.

Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles.

Porfire AS, Zabaleta V, Gamazo C, Leucuta SE, Irache JM.

Int J Pharm. 2010 May 5;390(1):37-44. doi: 10.1016/j.ijpharm.2009.08.017. Epub 2009 Aug 25.

PMID:
19712734
18.

PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.

Xie X, Tao Q, Zou Y, Zhang F, Guo M, Wang Y, Wang H, Zhou Q, Yu S.

J Agric Food Chem. 2011 Sep 14;59(17):9280-9. doi: 10.1021/jf202135j. Epub 2011 Aug 8.

PMID:
21797282
19.

Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.

Galindo-Rodriguez SA, Allemann E, Fessi H, Doelker E.

Crit Rev Ther Drug Carrier Syst. 2005;22(5):419-64. Review.

PMID:
16313233
20.

Pharmacokinetics and antitumor efficacy of paclitaxel-cyclodextrin complexes loaded in mucus-penetrating nanoparticles for oral administration.

Calleja P, Espuelas S, Corrales L, Pio R, Irache JM.

Nanomedicine (Lond). 2014 Jul;9(14):2109-21. doi: 10.2217/nnm.13.199. Epub 2014 Jan 28.

PMID:
24471503
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk